Yes, HIV can be transmitted through pre-ejaculatory fluid (precum) in the anus. Precum from an HIV-positive person who is not on effective treatment contains both HIV-infected white blood cells and free virus, making it capable of causing infection. While the viral load in precum is generally lower than in semen, the rectal lining is uniquely vulnerable to HIV, which means even smaller amounts of virus can establish infection.
HIV in Precum: What the Evidence Shows
Precum is a clear, lubricating fluid released from the penis during arousal, well before ejaculation. For a long time, it was unclear whether this fluid carried enough HIV to pose a real risk. A study published through the National Library of Medicine confirmed that precum from HIV-positive men who are not on treatment can contain significant levels of the virus. One participant’s precum sample contained 2,400 copies of HIV RNA, a level consistent with infectious potential.
There’s an important distinction based on treatment status. Among men on stable antiretroviral therapy with undetectable viral loads in their blood, none had detectable HIV in their precum, even though nearly 1 in 5 still had detectable virus in their semen. This means that for someone not on treatment, precum is a real transmission route. For someone on effective treatment with an undetectable viral load, the risk drops to zero, a principle known as U=U (Undetectable equals Untransmittable), confirmed by the CDC.
Why the Rectum Is Especially Vulnerable
The rectum is lined with a single layer of thin cells, unlike the much thicker, multi-layered tissue found in the mouth or on skin. This thin barrier is easier for HIV to cross, especially when microscopic tears occur during sex. Just beneath that fragile lining sits a dense concentration of the exact immune cells HIV targets: CD4+ T cells, macrophages, and dendritic cells. The lower rectum has an especially high concentration of macrophages that carry the CCR5 receptor, which HIV uses as a doorway into cells.
Specialized dendritic cells in rectal tissue can also capture HIV particles and hand them directly to T cells, essentially shuttling the virus deeper into the immune system. This combination of a fragile barrier and a high density of target cells is why receptive anal sex carries the highest per-act transmission risk of any sexual activity. The CDC estimates that risk at about 1 in 72 per act of unprotected receptive anal sex with an HIV-positive partner who is not on treatment.
Factors That Increase the Risk
Having an existing sexually transmitted infection in the rectum substantially raises your chances of acquiring HIV. Rectal gonorrhea is associated with a 2- to 17-fold increase in HIV risk, while rectal chlamydia raises the risk roughly 4-fold. Research from a Seattle STD clinic found that about 1 in 7 new HIV diagnoses among men who have sex with men could be attributed to a rectal STI. These infections cause inflammation that draws more immune cells to the area and can disrupt the already-thin rectal lining, creating easier entry points for HIV.
The 1-in-72 figure is an average across many encounters. Your actual risk in a single encounter could be higher or lower depending on the insertive partner’s viral load, whether there is rectal inflammation or an STI, and whether withdrawal happened before full ejaculation. Precum exposure alone likely carries somewhat lower risk than full ejaculation because the volume of fluid and total viral count are smaller, but it is not a safe alternative to protection.
How to Reduce the Risk
PrEP (pre-exposure prophylaxis) is a daily pill that dramatically reduces the chance of HIV infection. For receptive anal sex, PrEP reaches maximum protection after about 7 days of consistent daily use. Condoms, when used from the start of penetration, prevent precum contact with rectal tissue entirely. The delayed application of condoms (putting one on only before ejaculation) has been identified as a specific risk factor for HIV transmission among men who have sex with men, precisely because it allows precum to contact the rectal lining.
If you’ve already been exposed, post-exposure prophylaxis (PEP) is a course of medication that can prevent HIV from establishing infection if started quickly. HIV typically establishes itself in the body within 24 to 36 hours after exposure, so PEP needs to begin within 72 hours to be effective. The sooner it’s started, the better it works. After 72 hours, PEP is unlikely to help.
When and How to Get Tested
No HIV test can detect the virus immediately after exposure. A lab-based blood test drawn from a vein (fourth-generation antigen/antibody test) can detect HIV as early as 18 days after exposure, with full accuracy by 45 days. A rapid finger-stick version of the same test has a wider window, potentially taking up to 90 days for a definitive result. If you’re concerned about a specific exposure, testing at the 18-to-45-day mark with a lab-drawn blood test gives you the most reliable early answer.